The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 10,500 shares, an increase of 7.1% from the October 15th total of 9,800 shares. Based on an average daily trading volume, of 22,700 shares, the short-interest ratio is currently 0.5 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 0.2 %

Shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.04 during trading hours on Friday, reaching $19.46. The stock had a trading volume of 27,506 shares, compared to its average volume of 21,879. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $17.04 and a twelve month high of $20.85. The stock’s 50 day moving average is $19.88 and its 200 day moving average is $18.99.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, November 15th. Stockholders of record on Saturday, November 1st will be given a dividend of $0.2891 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 5.94%. The ex-dividend date of this dividend is Friday, October 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.